Federal Circuit Affirms Obviousness Ruling for ImmunoGen’s Cancer Drug Dosing Patent Application

ImmunoGen, Inc. v. Stewart Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed that ImmunoGen, Inc. was not entitled to a patent for a specific dosing regimen of its cancer drug, IMGN853 (mirvetuximab soravtansine), used to…

Read More

Court Clarifies What Counts as “Domestic Industry” for Patent Protection at the ITC

Lashify, Inc. v. Int’l Trade Comm’n Authored by: Jeremy J. Gustrowsky In a significant decision for patent owners who manufacture their products overseas, the Federal Circuit in Lashify, Inc. v. International Trade Commission clarified what activities can qualify as a…

Read More

Apple, LG, and Google Succeed in Invalidating Most Gesture Tech Patent Claims, but Two Survive

Apple Inc. v. Gesture Tech. Partners, LLC Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed a ruling by the Patent Trial and Appeal Board (PTAB) that invalidated most claims of U.S. Patent No. 7,933,431, owned…

Read More

Stem Cell Patent Survives Challenge Over Prior Art and Claim Construction

Restem, LLC v. Jadi Cell, LLC Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed the validity of Jadi Cell, LLC’s U.S. Patent No. 9,803,176, which covers a method for obtaining stem cells from the subepithelial…

Read More

Patent Board Affirms Rejection of DeepMind’s Machine Learning Patent Application, Citing Obviousness and Lack of Patent-Eligible Subject Matter

USPTO Authored by: Jeremy J. Gustrowsky A recent decision from the Patent Trial and Appeal Board (PTAB) highlights the challenges of patenting advances in artificial intelligence and machine learning. In the appeal concerning U.S. Patent Application No. 16/319,040, filed by…

Read More

Understanding Patents: What Every Inventor Should Know

When it comes to patents, understanding what they protect is key for inventors and creators alike. The most common type, the utility patent, safeguards useful inventions. This could encompass a wide range of innovations, such as processes, machines, chemical compounds,…

Read More

IPR Decisions Don’t Always Block Patent Claims in Court, Says Federal Circuit

Kroy IP Holdings, LLC v. Groupon, Inc Authored by: Jeremy J. Gustrowsky In the recent case of Kroy IP Holdings, LLC v. Groupon, Inc., the Federal Circuit addressed a key question in patent law: Does a decision by the Patent…

Read More

Patent Owners Get a Win: Federal Circuit Limits Collateral Estoppel from PTAB Decisions

Kroy IP Holdings, LLC v. Groupon, Inc Authored by: Jeremy J. Gustrowsky In a significant decision for patent owners, the Federal Circuit recently clarified when a prior Patent Trial and Appeal Board (PTAB) decision can prevent a patentee from asserting…

Read More

Plant-Based Albumin Patent Survives Import Challenge at the ITC

Wuhan Healthgen Biotechnology Corp. v. Int’l Trade Comm’n Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed the International Trade Commission’s (ITC) finding that Wuhan Healthgen Biotechnology Corp. infringed Ventria Bioscience Inc.’s U.S. Patent No. 10,618,951,…

Read More

Federal Circuit Clarifies “Comprising Tungsten” Means Elemental Tungsten—But Patent Still Obvious

HD Silicon Sols. LLC v. Microchip Tech. Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit addressed a key issue in the patent dispute between HD Silicon Solutions LLC and Microchip Technology Inc. over U.S. Patent…

Read More

Patent Office Can Continue Reexams Even After IPRs and Patent Expiration, Court Says

In re Gesture Tech. Partners, LLC Authored by: Jeremy J. Gustrowsky A recent decision has clarified how patent challenges can proceed even after multiple rounds of review and the expiration of the patent itself. Gesture Technology Partners, LLC found itself…

Read More

Navigating Patent Myths: Unlocking Your Business Potential

Common misconceptions about the patent system can really hold businesses back from seizing growth opportunities and securing their place in the market, especially when there’s fierce competition out there. One of the biggest myths? “If I patent it, I can…

Read More